The thyroid gland iscommonly included in the radiation field during treatment ofnonthy roidal neoplasticdisease of the h ead and neck. As a result, thyroid abnormalities sometimes occurfollowingexternal irradiation. Wereport an unusual case of radiotherapy-associated Graves ophthalmopathy 5 months after adjuvant external irradiation ofthe head and neck in a euthyroid patient who had undergone widelocalexcision of squamouscellcarcinoma from the floor of the mouth.
and, occasionally, dermop athy refer red to as pretibial or localized myxed em a. The terms Graves disease and hyperthyroidism are not syno nym ous because so m e patients have ophthalmopath y with no evidence of clinical hyp erthyroidism . Graves ophthalmopathy is an autoimmune disease in which the volume of both th e ext raoc ular muscles and retro -orbital connective tissues is increased.v" At di agn osis of Gr aves hypert hyro idism , approximatel y 20 to 25% of pa tient s have clinically obv io us Graves op htha lm opa thy th at includ es p roptosis and periorbital edem a, excluding the eye signs of thyroid hormone excess (lid retracti on and sta re) ." However, on ultrasonography, com pu ted tomograph y (CT), or magne tic reso na nce im agin g of th e orbi ts, many m ore patien ts have evidence of oph th almopa thy, pri m ar ily enl argement of ret ro-ocular muscles. 10 Similarly, most pati ents with op h thalmopathy have evide nce ofthyroid disease,but in about 10% ofpati ents, thyro id disease is not clinicallyobvious. 8 Such patients are label ed as havin g "euthyroid" Graves opht halmopath y, but th ey often have high seru m antithyroid autoantibod y con centrati ons or circul at in g th yroid-specific T cells.I I We rep ort a case, to our knowled ge th e first such repo rt, of rad iotherap y-associated euthyroid Graves op h tha lm opa thy following excision of squamous cell carcinoma fro m the floor of the m outh .
Case report
A 49-year-o ld euthyroid man with no fami ly history of thyroid disease was referred to our clini c with biopsyiden tified squa mous cell carcin oma of th e floor of th e mouth . A spiral CT of the neck, fro m the sku ll base th rough the lung apices, was per for m ed. A regio n of increased den sity measuring 1.5 x 1.5 cm, con sistent with a ma ss, was identified in the anteri o r floor of th e www.ent j ournal.com • 533 mo uth. The lesion was below the intri nsic ton gue mu sculature but within th e m ucosa overlying the extrinsic to ngue mu sculature, abutti ng and possibly involving th e anterior portions ofthe genioglossus and mylohyoid mu scles (figure 1).
Wid e local excision of th e floor of the mouth was performed, and th e neoplasm was noted to be approxima tely 2.0 x 1.5 em . The specimen was sent for frozen section, and m argins proved to be negative. However, on final patho logic evaluatio n, th e deep margin was positive. After an un eventful recovery, the patient was seen in radiation oncology for postop erative adjuvant rad ioth erapy.
Per prot ocol, th e patient received radiation to the pr im ary site and th e regional nod es with a combination of photons and electrons. Th e prim ary site and upper cervical nod es received 5,960 cGy,and the lower cervical and supraclavicular nod es received 5,040 cGy.A midline block partially shielded the larynx and the thyroid gland (figure 2). The estimated dose to th e thyroid gland was less than 5,000 cGy, with abo ut 50% of th e gland receiving less than 3,000 cGy.
Approximately 5 months after postop erative rad iotherapy,the patient experienced diplopia and was referred to an ophthalmologist, who suspected Graves ophthalmopathy. CT of th e orbit revealed diffuse enlargement of the belly of th e extraocular muscles, consistent with 534 · www.entjournal.com class IV ophthalmo pa thy according to th e guidelines of th e Ameri can Thyroid Association " (figure 3). Subsequentl y, the patient was referred to an endoc rinologist, who noted on physical examination a diffusively enlarged sym me trical thyroid gland with left eye prop tosis. The patient had no classicsymptom sof hyperthyroidi sm (heat intolerance, palpita tions, weight loss) and had gained 6 po unds since his rad iation treatm ent.
Diagnostic thyroid fun ction testingwas cond ucted and revealed a thyro tropi n level of less than 0.018 mI U/ L (norma l, 0.40 to 4.00 mIU/L), a T 3 level of 229.0 ng/d l (no rmal, 82 to 179 ng/dl) , and a free T 4l evel of 2.010 ng/dl (no rmal, 0.8 to 1.9 ng/dl) . Th e pat ient's seru m thyrot ropin immunoglobulin level was slightly elevated at 220 mg/dl (no rm al, < 130 mg/d l), con firm ing Graves disease. Altho ugh th e pati ent 's free T 4l evel was slightly elevated and his th yrotrop in level was abnorma lly low, he appeared clinically euthyroi d and was n ot treated with antithyro id medicati on s. He received predn isone for his Graves ophthalmo pathy, and with the use of prisms his vision improved. Subsequ ent serial testin g (at l-rnonth int ervals) of seru m thyro id function and thyro tro pin autoa ntibodies sho wed a spo ntane ous ret urn to normal levels. Prednison e therapy was discontinu ed, and after 2 years, the patient continues to be euthyroid with stable Graves op hthalm op athy and no recurrence of carc inoma. 
Discussion
Radiation therapy is widely used to treat lymphomas and tumors of the central nervous system and head and neck. Exposure of nontarget organs, such as the thyroid gland, potentially leading to adverse effects, is unavoidable. Radiation effects on the thyroid gland were first reported in the 1920s. 13 In 1973,Wasnich et al reported euthyroid Graves ophthalmopathyafter neck irradiation for nonthyroidal tumors in 2 patients: 1 being treated for Hodgkin lymphoma and 1receiving adjuvant radiotherapyafterradical mastectomyfor carcinoma. " A 1991 retrospective analysis of 1,787 patients with Hodgkin disease who had been treated with external irradiation revealed that Graves hyperthyroidism developed in 30 patients, with concomitant ophthalmopathy in 17, but Gravesophthalmopathywith maintenance ofa euthyroid state occurred in only 1patient."Gravesophthalmopathy with concomitant hyperthyroidism is more commonly reported following radiation treatment.":"
Radiotherapy-induced ophthalmopathy associated with Graves disease most likely results from an autoimmune reaction secondary to athyroid injurycaused by the radiation. Evidence for this premise isthe development or worsening of Graves ophthalmopathy after radioiodine therapy for Graves hyperthyroidism. ":" The changes are often mild and transient, at least in patients who have mild or no ophthalmopathy before treatment. Wasnich et al postulated that the ophthalmopathy observed after external irradiation in their patients and that seen after radioiodine therapy resulted from similar pathogenic processes."
Further, the histologic effects ofexternal radiation and Volume 87, Number 9 gamma (radioiodine) on the thyroid have been shown to be qualitatively similar." High doses of irradiation initially produce acute epithelial injury, associated with necrotizing vasculitis and thrombosis. Some investigators postulate that the coincident release of thyroid cell components, namely thyrotropin-receptor antigen ,isthe antigenic stimulus for the post-treatment rises in serum antithyroid antibodies that have been observed." Mechanistic observations, plus the frequent concomitant occurrence of Graves hyperthyroidism and Graves ophthalmopathy, have led to the suggestion that activation of the immune system must be secondary to an antigen shared by both tissues. The presence of the thyrotropin receptor messenger ribonucleic acid (mRNA) and protein in orbital fibroblasts and adipocytes suggests that mRNA may be the antigen involved in the pathogenesis of ophthalmopathy.V' :"
In radioiodine treatment for hyperthyroidism, posttreatment rises of serum antithyroid antibodies can be dramatic and usually occur within 2 to 6 mpnths,25 These observations are strikingly similar to our reported case, in which serum antibody levels increased within this time period (but were mild and transient). The obvious difference is that our patient had a normal thyroid gland before irradiation and no evidence of orbitopathy.
Radiotherapy-associated thyroid abnormalities are underestimated and -underreported, and as use of radiation therapy in head and neck tumors continues to expand, thyroid abnormalities due to inadvertent thyroid injury are likely to increase.Our case report supports Wasnich's hypothesis that a thyrotropin-receptor antigenic stimulus following external irradiation injury leads to Graves ophthalmopathy. A similar phenomenon in radioiodine-induced exacerbation of Graves ophthalmopathy in the treatment of hyperthyroidism has been well documented.
The total radiotherapy dose and radiation volume to the thyroid gland are among the most important risk factors for development of Graves disease and other thyroid abnormalities. Therefore, minimal exposure of the thyroid gland during neck irradiation and careful, long-term evaluation of thyroid function after radiotherapy are essential in managing this rare and unusual complication.
